267 related articles for article (PubMed ID: 21463124)
21. Fludarabine and rituximab for relapsed or refractory hairy cell leukemia.
Gerrie AS; Zypchen LN; Connors JM
Blood; 2012 Mar; 119(9):1988-91. PubMed ID: 22223825
[TBL] [Abstract][Full Text] [Related]
22. CD56-Positive Acute Myeloid Leukemia Following Treatment of Hairy Cell Leukemia with Cladribine - Report of 2 Cases and Review of the Literature.
Colovic N; Marisavljevic D; Kraguljac-Kurtovic N; Bogdanovic A; Gotic M
Arch Iran Med; 2019 May; 22(5):269-271. PubMed ID: 31256601
[TBL] [Abstract][Full Text] [Related]
23. Hairy cell leukemia: a 'hair-raising' update.
Topp ZZ; Saven A
Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia.
Bhargava R; Barbashina V; Filippa DA; Teruya-Feldstein J
Leuk Lymphoma; 2004 May; 45(5):1043-8. PubMed ID: 15291365
[TBL] [Abstract][Full Text] [Related]
25. Hairy cell leukemia: a successful model for experimental therapeutics--pentostatin and new ideas.
Grever MR
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():25-8. PubMed ID: 21599604
[TBL] [Abstract][Full Text] [Related]
26. Infectious and immunosuppressive complications of purine analog therapy.
Cheson BD
J Clin Oncol; 1995 Sep; 13(9):2431-48. PubMed ID: 7666104
[TBL] [Abstract][Full Text] [Related]
27. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
28. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D
Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Else M; Dearden CE; Catovsky D
Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
[TBL] [Abstract][Full Text] [Related]
30. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
Polliack A
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():41-51. PubMed ID: 9570679
[TBL] [Abstract][Full Text] [Related]
31. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
Yang MH; Ho CH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
[TBL] [Abstract][Full Text] [Related]
32. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA
Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799
[TBL] [Abstract][Full Text] [Related]
33. Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping.
Tallman MS
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():65-8. PubMed ID: 21463116
[TBL] [Abstract][Full Text] [Related]
34. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
35. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.
Nieva J; Bethel K; Saven A
Blood; 2003 Aug; 102(3):810-3. PubMed ID: 12663446
[TBL] [Abstract][Full Text] [Related]
36. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
[TBL] [Abstract][Full Text] [Related]
37. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
[TBL] [Abstract][Full Text] [Related]
38. Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency.
Gozzetti A; Bacchiarri F; Raspadori D; Sicuranza A; Sammartano V; Bocchia M
Rev Recent Clin Trials; 2023; 18(4):300-303. PubMed ID: 37779396
[TBL] [Abstract][Full Text] [Related]
39. Purine analogs in the treatment of chronic lymphocytic leukemia.
Pott C; Hiddemann W
Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
[TBL] [Abstract][Full Text] [Related]
40. Purine analogs in lymphoproliferative disorders.
Cheson BD
Leuk Lymphoma; 1993; 11 Suppl 2():153-9. PubMed ID: 7907252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
